| Date Filed | Type | Description |
| 05/19/2023 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 12,000 options to buy
@ $2.52, valued at
$30.2k
|
|
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2022 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 6,000 restricted stock units
@ $0 |
|
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2020 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Sold 100 shares
@ $4, valued at
$400
Sold 7,260 shares
@ $4.01, valued at
$29.1k
|
|
| 08/28/2020 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Sold 2,200 shares
@ $4.296, valued at
$9.5k
Sold 5,440 shares
@ $4.09, valued at
$22.2k
|
|
| 05/08/2020 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 1,428 options to buy
@ $3.65, valued at
$5.2k
|
|
| 05/10/2019 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 20,000 options to buy
@ $0.5834, valued at
$11.7k
|
|
| 06/22/2018 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 options to buy
@ $105.26, valued at
$947.3k
|
|
| 06/04/2018 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 2,758 shares
@ $99.38, valued at
$274.1k
Sold 10,042 shares
@ $100.33, valued at
$1M
Sold 2,100 shares
@ $101.37, valued at
$212.9k
Sold 100 shares
@ $101.97, valued at
$10.2k
Exercised 15,000 options to buy
@ $27.28, valued at
$409.2k
|
|
| 05/17/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/11/2017 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC |
| 06/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/26/2016 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 18,000 options to buy
@ $3.33, valued at
$59.9k
|
|
| 01/29/2016 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 19,428 options to buy
@ $6.14, valued at
$119.3k
|
|
| 07/10/2015 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Granted 6,286 options to buy
@ $14.96, valued at
$94k
|
|
| 06/11/2015 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 17,750 options to buy
@ $22.18, valued at
$393.7k
|
|
| 06/03/2015 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 11,250 options to buy
@ $131.21, valued at
$1.5M
|
|
| 05/14/2015 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on aTYR PHARMA INC|
Txns:
| Converted 92,306 shares
@ $0
Converted 1,758,158 shares
@ $0
Converted 893,655 options to buy
@ $0
Converted 2,400,000 options to buy
@ $0
Converted 3,600,000 options to buy
@ $0
Converted 4,320,173 options to buy
@ $0
Converted 2,127,660 options to buy
@ $0
Converted 1,536,787 options to buy
@ $0 |
|
| 05/14/2015 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Sold 38,400 shares
@ $19.96, valued at
$766.5k
Exercised 38,400 options to buy
@ $10.44, valued at
$400.9k
|
|
| 06/13/2014 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 17,750 options to buy
@ $13.16, valued at
$233.6k
|
|
| 06/06/2014 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 15,000 options to buy
@ $59.25, valued at
$888.8k
|
|
| 05/23/2014 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 22,792 shares
@ $52.954, valued at
$1.2M
Sold 2,500 shares
@ $54.2142, valued at
$135.5k
Sold 6,908 shares
@ $55.4684, valued at
$383.2k
Sold 2,800 shares
@ $56.1929, valued at
$157.3k
Exercised 10,000 options to buy
@ $7.08, valued at
$70.8k
Exercised 10,000 options to buy
@ $14.74, valued at
$147.4k
Exercised 15,000 options to buy
@ $15.91, valued at
$238.7k
|
|
| 06/13/2013 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Bought 23,171 shares
@ $9.5993, valued at
$222.4k
|
|
| 06/13/2013 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on MOMENTA PHARMACEUTICALS INC|
Txns:
| Granted 17,750 options to buy
@ $14.42, valued at
$256k
|
|
| 06/12/2013 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on Verastem, Inc.|
Txns:
| Bought 25,000 shares
@ $9.2191, valued at
$230.5k
|
|
| 06/10/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2013 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on Verastem, Inc. |
| 04/19/2013 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on Verastem, Inc. |
| 06/25/2012 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 15,000 options to buy
@ $11.33, valued at
$170k
|
|
| 06/15/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2012 |
4
| CLARKE JOHN K (Director) has filed a Form 4 on Verastem, Inc. |
|